Questions of Copyright

Health and Quality of Life Outcomes

Volumn 10, Issue , 2012, Pages

  Anfray, Caroline ^a   Emery, Marie Pierre ^b   Conway, Katrin ^b   Acquadro, Catherine ^b  

^a MAPI Institute   (France)

^b MAPI Research Trust   (France)

Author keywords

Copyright; Intellectual property; Patient reported outcome measures; Patient reported outcomes

Indexed keywords

ACCESS TO INFORMATION; HUMAN; INSTRUMENT; LETTER; ORGANIZATION AND MANAGEMENT; OUTCOME ASSESSMENT; PATENT; PATIENT REPORTED OUTCOME; PUBLICATION; PUBLISHING; REPRODUCIBILITY; SELF REPORT; FRANCE; LEGAL ASPECT; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRE; STATISTICS;

COPYRIGHT; FRANCE; HUMANS; INTELLECTUAL PROPERTY; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84856335783     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-10-16     Document Type: Letter

References (7)

1. Anfray C, Emery MP. Use of PRO instruments: licensing and copyright issues [abstract]. Qual Life Res 2006, 15(suppl 1):A-112.
2. Anfray C, Emery MP. Access and use of Patient-Reported Outcomes (PRO) instruments in international studies: authorship and copyright issues [abstract]. Qual Life Res 2007, 16(suppl):A-21.
3. Anfray C, Emery MP. Use of Patient-Reported Outcomes (PRO) Instruments: Copyright Issues [abstract]. Value in Health 2007, 10(3):A189.
4. Anfray C. Patient-reported outcomes instruments: bridging the gap between international copyright laws and common practice for developers and users-a case example. Qual Life Res 2009, 18(10):1281-1283. 10.1007/s11136-009-9552-5, 19911308.
5. Revicki DA, Schwartz CE. Intellectual property rights and good research practice. Qual Life Res 2009, 18(10):1279-1280. 10.1007/s11136-009-9551-6, 19885743.
6. . US Department of Health, Food and Drug Administration Patient-reported outcome measures: use in medical product development to support labeling claims. Federal Register 2009, 74(35):65132-133. Available at http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf, US Department of Health, Food and Drug Administration.
7. European Medicines Agency Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products. London 2006, Available at http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003637.pdf, European Medicines Agency.